Clinicians’ Perspectives of Twice-Weekly Rivastigmine Patches for Alzheimer’s Disease Treatment in Spain: The VIITAL 2S Study

Gerard Piñol-Ripoll,1,2 Mario Salas Carrillo3,4 On behalf of the VIITAL 2S study group1Cognitive Disorders Unit, Hospital Universitari Santa Maria - IRBLleida, Lleida, Spain; 2Alzheimer’s Disease and other Cognitive Disorders Group - Service of Neurology, Hospital Clínic de Barcelona - Fundació Rece...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Piñol Ripoll G, Salas Carrillo M
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Dove Medical Press 2025-04-01
Ráidu:	Patient Preference and Adherence
Fáttát:	alzheimer’s disease spain rivastigmine transdermal patch twice-weekly posology compliance
Liŋkkat:	https://www.dovepress.com/clinicians-perspectives-of-twice-weekly-rivastigmine-patches-for-alzhe-peer-reviewed-fulltext-article-PPA
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!